| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck JA Bonner, PM Harari, J Giralt, N Azarnia, DM Shin, RB Cohen, CU Jones, ... New England Journal of Medicine 354 (6), 567-578, 2006 | 6456 | 2006 |
| Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash … JA Bonner, PM Harari, J Giralt, RB Cohen, CU Jones, RK Sur, D Raben, ... The lancet oncology 11 (1), 21-28, 2010 | 2443 | 2010 |
| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1148 | 2019 |
| Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck SM Huang, JM Bock, PM Harari Cancer research 59 (8), 1935-1940, 1999 | 1029 | 1999 |
| Understanding resistance to EGFR inhibitors—impact on future treatment strategies DL Wheeler, EF Dunn, PM Harari Nature reviews Clinical oncology 7 (9), 493-507, 2010 | 787 | 2010 |
| Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor … SM Huang, PM Harari Clinical Cancer Research 6 (6), 2166-2174, 2000 | 773 | 2000 |
| Image guidance for precise conformal radiotherapy TR Mackie, J Kapatoes, K Ruchala, W Lu, C Wu, G Olivera, L Forrest, ... International Journal of Radiation Oncology* Biology* Physics 56 (1), 89-105, 2003 | 685 | 2003 |
| Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members DL Wheeler, S Huang, TJ Kruser, MM Nechrebecki, EA Armstrong, ... Oncogene 27 (28), 3944-3956, 2008 | 664 | 2008 |
| Epidermal growth factor receptor inhibition strategies in oncology PM Harari Endocrine-related cancer 11 (4), 689-708, 2004 | 618 | 2004 |
| Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva) P Chinnaiyan, S Huang, G Vallabhaneni, E Armstrong, S Varambally, ... Cancer research 65 (8), 3328-3335, 2005 | 501 | 2005 |
| Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR) combining anti-EGFR antibody with tyrosine kinase inhibitor S Huang, EA Armstrong, S Benavente, P Chinnaiyan, PM Harari Cancer research 64 (15), 5355-5362, 2004 | 497 | 2004 |
| Enhanced radiation sensitivity in HPV-positive head and neck cancer RJ Kimple, MA Smith, GC Blitzer, AD Torres, JA Martin, RZ Yang, CR Peet, ... Cancer research 73 (15), 4791-4800, 2013 | 438 | 2013 |
| p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma CH Chung, Q Zhang, CS Kong, J Harris, EJ Fertig, PM Harari, D Wang, ... Journal of clinical oncology 32 (35), 3930, 2014 | 416 | 2014 |
| Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22) A Eisbruch, J Harris, AS Garden, CKS Chao, W Straube, PM Harari, ... International Journal of Radiation Oncology* Biology* Physics 76 (5), 1333-1338, 2010 | 410 | 2010 |
| Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) SM Huang, J Li, EA Armstrong, PM Harari Cancer research 62 (15), 4300-4306, 2002 | 390 | 2002 |
| The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy TS Hong, WA Tomé, RJ Chappell, P Chinnaiyan, MP Mehta, PM Harari International Journal of Radiation Oncology* Biology* Physics 61 (3), 779-788, 2005 | 369 | 2005 |
| Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results SM Huang, PM Harari Investigational new drugs 17, 259-269, 1999 | 317 | 1999 |
| Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy JN Sarkaria, PM Harari Head & neck 16 (2), 107-111, 1994 | 307 | 1994 |
| Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab D Curran, J Giralt, PM Harari, KK Ang, RB Cohen, MS Kies, J Jassem, ... Journal of clinical oncology 25 (16), 2191-2197, 2007 | 303 | 2007 |
| Biology of interactions: antiepidermal growth factor receptor agents PM Harari, GW Allen, JA Bonner Journal of Clinical Oncology 25 (26), 4057-4065, 2007 | 298 | 2007 |
